Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jürgen Burhenne

1-50 of 120 results

CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole

scientific article

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

scientific article published on 03 July 2006

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

scientific article published on July 2004

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

scientific article

Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients

scientific article

Expanding the chemical scope of RNA:methyltransferases to site-specific alkynylation of RNA for click labeling

scientific article published on 30 October 2010

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

scientific article

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

scientific article published in July 2005

Detection of RNA modifications.

scientific article

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

article

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine

scientific article published in 2006

In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins

scientific article published on November 2005

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction

scientific article published on July 2003

Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

article

High absolute bioavailability of methylene blue given as an aqueous oral formulation

scientific article published on 23 September 2008

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

scientific article

A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions.

scientific article published on 8 February 2013

Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis

scientific article published on 23 October 2006

Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy

scientific article published on 21 September 2011

Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania

scientific article

Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring

scientific article

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

scientific article published on 18 September 2006

Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics

scientific article published on October 2004

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

scientific article published on 16 August 2011

Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso

scientific article published on January 2005

Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas

scientific article

Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration

scientific article

Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans

scientific article

Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial

scientific article published on 15 September 2014

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria

scientific article published on 13 October 2004

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

scientific article published in May 2003

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL

scientific article published on June 2002

Development of capillary electrophoresis methods for the analysis of fluoroquinolones and application to the study of the influence of humic substances on their photodegradation in aqueous phase

article

CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir

scientific article

A multifunctional bioconjugate module for versatile photoaffinity labeling and click chemistry of RNA.

scientific article

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement

scientific article published in November 2001

Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent

scientific article published in July 2009

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

scientific article published on 23 October 2012

Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity

scientific article published on 18 November 2009

Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.

scientific article published on 15 January 2012

Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype.

scientific article published in September 2006

Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters

scientific article

Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman

scientific article published in September 2006

Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso

scientific article published on 29 March 2010

No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment

scientific article

Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure

scientific article published on 7 January 2011

Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications.

scientific article published on 2 July 2007

Oral contraception does not alter single dose saquinavir pharmacokinetics in women

scientific article published in March 2004

CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores

scientific article published on January 2014

Steady-state pharmacokinetics and metabolism of voriconazole in patients.

scientific article published on 13 June 2013